Robert Wild to Cardiovascular Diseases
This is a "connection" page, showing publications Robert Wild has written about Cardiovascular Diseases.
Connection Strength
5.166
-
A Possible Screening Marker for Cardiovascular Disease in Polycystic Ovary Syndrome. J Womens Health (Larchmt). 2022 06; 31(6):751-752.
Score: 0.617
-
Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative. Menopause. 2021 05 03; 28(6):610-618.
Score: 0.574
-
Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. J Clin Lipidol. 2021 May-Jun; 15(3):423-430.
Score: 0.570
-
Insights from the Women's Health Initiative: individualizing risk assessment for hormone therapy decisions. Semin Reprod Med. 2014 Nov; 32(6):433-7.
Score: 0.365
-
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010 May; 95(5):2038-49.
Score: 0.267
-
Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts? Semin Reprod Med. 2009 Jul; 27(4):299-305.
Score: 0.252
-
Endogenous androgens and cardiovascular risk. Menopause. 2007 Jul-Aug; 14(4):609-10.
Score: 0.220
-
Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician. Clin Obstet Gynecol. 2007 Mar; 50(1):226-43.
Score: 0.215
-
Healthy Lifestyle Index and Risk of Cardiovascular Disease Among Postmenopausal Women With Normal Body Mass Index. J Am Heart Assoc. 2023 06 20; 12(12):e029111.
Score: 0.166
-
Association of Preterm Birth With Prevalent and Incident Hypertension, Early-Onset Hypertension, and Cardiovascular Disease in the Women's Health Initiative. Am J Cardiol. 2023 04 01; 192:132-138.
Score: 0.162
-
The severity of individual menopausal symptoms, cardiovascular disease, and all-cause mortality in the Women's Health Initiative Observational Cohort. Menopause. 2022 Dec 01; 29(12):1365-1374.
Score: 0.159
-
Association of infertility with atherosclerotic cardiovascular disease among postmenopausal participants in the Women's Health Initiative. Fertil Steril. 2022 05; 117(5):1038-1046.
Score: 0.152
-
Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women. Diabetes Care. 2022 01 01; 45(1):222-231.
Score: 0.150
-
Dietary cholesterol and egg intake in relation to incident cardiovascular disease and all-cause and cause-specific mortality in postmenopausal women. Am J Clin Nutr. 2021 04 06; 113(4):948-959.
Score: 0.143
-
Role of Lipid Management in Women's Health Preventive Care. Obstet Gynecol Clin North Am. 2021 Mar; 48(1):173-191.
Score: 0.142
-
Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation. J Womens Health (Larchmt). 2020 09; 29(9):1150-1159.
Score: 0.136
-
Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019 09 07; 40(34):2849-2855.
Score: 0.128
-
Metabolic aspects of polycystic ovary syndrome. Semin Reprod Endocrinol. 1997 May; 15(2):105-10.
Score: 0.109
-
National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. J Clin Lipidol. 2015 Mar-Apr; 9(2):129-69.
Score: 0.094
-
Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 1995 Jan 16; 98(1A):27S-32S.
Score: 0.093
-
The gynecologist and the prevention of cardiovascular disease. Am J Obstet Gynecol. 1995 Jan; 172(1 Pt 1):1-13.
Score: 0.093
-
The gynecologist and cardiovascular disease: a window of opportunity for prevention. J Soc Gynecol Investig. 1994 Apr-Jun; 1(2):107-17.
Score: 0.088
-
Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials. Menopause. 2013 Mar; 20(3):254-60.
Score: 0.081
-
Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1985 Nov; 61(5):946-51.
Score: 0.049
-
Hysterectomy prevalence and cardiovascular disease risk factors in American Indian women. Maturitas. 2005 Nov-Dec; 52(3-4):328-36.
Score: 0.048
-
Polycystic ovary syndrome: a risk for coronary artery disease? Am J Obstet Gynecol. 2002 Jan; 186(1):35-43.
Score: 0.038
-
Risk factors: assessment and preventive measures. Clin Obstet Gynecol. 1998 Dec; 41(4):966-75.
Score: 0.030
-
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jan; 97(1):28-38.e25.
Score: 0.019
-
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA. 1998 May 13; 279(18):1445-51.
Score: 0.007